Cargando…
Overlooked potential of positrons in cancer therapy
Positron (β(+)) emitting radionuclides have been used for positron emission tomography (PET) imaging in diagnostic medicine since its development in the 1950s. Development of a fluorinated glucose analog, fluorodeoxyglucose, labelled with a β(+) emitter fluorine-18 ((18)F-FDG), made it possible to i...
Autores principales: | Hioki, Takanori, Gholami, Yaser H., McKelvey, Kelly J., Aslani, Alireza, Marquis, Harry, Eslick, Enid M., Willowson, Kathy P., Howell, Viive M., Bailey, Dale L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843622/ https://www.ncbi.nlm.nih.gov/pubmed/33510222 http://dx.doi.org/10.1038/s41598-021-81910-4 |
Ejemplares similares
-
Individualised dosimetry and safety of SIRT for intrahepatic cholangiocarcinoma
por: Willowson, Kathy P., et al.
Publicado: (2021) -
Theranostic SPECT reconstruction for improved resolution: application to radionuclide therapy dosimetry
por: Marquis, H., et al.
Publicado: (2021) -
A Comparison of 2D and 3D Kidney Absorbed Dose Measures in Patients Receiving (177)Lu-DOTATATE
por: Willowson, Kathy P, et al.
Publicado: (2018) -
Feasibility and accuracy of single time point imaging for renal dosimetry following (177)Lu-DOTATATE (‘Lutate’) therapy
por: Willowson, Kathy P., et al.
Publicado: (2018) -
Towards personalised dosimetry in patients with liver malignancy treated with (90)Y-SIRT using in vivo-driven radiobiological parameters
por: Gholami, Yaser H., et al.
Publicado: (2022)